Skip to content
HomeLatest newsTwo scientists win the 2019 Dr. Paul Janssen Award for biomedical research
2019 Dr. Paul Janssen Award winners Arthur Horwich, M.D., (left) and Franz-Ulrich Hartl, M.D.
2019 Dr. Paul Janssen Award winners Arthur Horwich, M.D., (left) and Franz-Ulrich Hartl, M.D.

Two scientists win the 2019 Dr. Paul Janssen Award for biomedical research

Learn about the revolutionary work they’re both doing in the field of neurodegenerative disease that could prove important in fighting often-fatal conditions.

2019 Dr. Paul Janssen Award winners Arthur Horwich, M.D., (left) and Franz-Ulrich Hartl, M.D.

Parkinson’s disease. Huntington’s disease. Lou Gehrig’s disease.

It’s neurodegenerative illnesses like these that this year’s winners of the Dr. Paul Janssen Award for Biomedical Research are focusing their extraordinary talents on decoding.

Franz-Ulrich Hartl, M.D., of the Max Planck Institute of Biochemistry in Germany, and Arthur Horwich, M.D., of the Yale School of Medicine and Howard Hughes Medical Institute in the U.S., were chosen for the award based on their groundbreaking insights into a process called chaperone-mediated protein folding and its importance in cellular health—particularly in preventing proteins from aggregating in a way that could potentially lead to the fatal symptoms neurodegenerative diseases can cause.

Dr. Hartl and Dr. Horwich join 16 scientists who’ve received the award to date, including three who ultimately went on to win the Nobel Prize.

Honoring scientific pioneers like Dr. Paul Janssen

Johnson & Johnson created the award in 2004 to honor Paul Janssen, Ph.D., the innovative founder of what is now called the Janssen Pharmaceutical Companies of Johnson & Johnson.

Each year, the award is given to the most passionate and creative scientist or scientists in basic or clinical research whose achievements have made, or have strong potential to make, a measurable impact on human health through the diagnosis, treatment or prevention of disease.

Dr. Hartl and Dr. Horwich, who were selected by an independent committee of world-renowned researchers, join 16 scientists who’ve received the award to date, including three who ultimately went on to win the Nobel Prize.

They’ll share a $200,000 cash prize to further their work and each receive a sculpture with an inspirational inscription of “What’s New?” It’s a nod to the question Dr. Paul, as he was affectionately known, asked daily in his lab to encourage his colleagues to seek new ways to help patients—and inspire the next big health breakthroughs.

Along with David Julius, Ph.D., who won the Dr. Paul Janssen Award in 2013, Drs. Hartl and Horwich were also just honored with the 2020 Breakthrough Prize in Life Science for the transformative advances they’ve made toward understanding living systems and extending human life.

More from Johnson & Johnson

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.

What is a rheumatic disease?

More than 200 conditions are classified as rheumatic diseases, including rheumatoid arthritis, lupus and Sjögren’s disease. They tend to affect the joints and connective tissues, causing pain and swelling and impacting quality of life. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.